We are live on
!
Find out more
BC
Blackhill Capital Portfolio holdings
AUM
$1.94B
1-Year Est. Return
18.09%
This Fund
S&P 500
This Quarter
Est. Return
+8.48%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$1.74B
AUM Growth
+$125M
(+7.7%)
Cap. Flow
-$7.84M
Cap. Flow
% of AUM
-0.45%
Top 10 Holdings %
Top 10 Hldgs %
93.03%
Holding
53
New
–
Increased
–
Reduced
6
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$3.14M |
| 2 |
Johnson & Johnson
JNJ
|
+$2.19M |
| 3 |
AbbVie
ABBV
|
+$1.87M |
| 4 |
Kenvue
KVUE
|
+$438K |
| 5 |
Baxter International
BAX
|
+$167K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 69.9% |
| 2 | Healthcare | 18.32% |
| 3 | Technology | 6.37% |
| 4 | Financials | 1.37% |
| 5 | Industrials | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Williams-Sonoma
WSM
$29.5B
| $1.21B | 69.63% |
7,808,428
| – | – |
|
2
Eli Lilly
LLY
$1.08T
| $130M | 7.5% |
147,163
-35
| -0% | -$31.5K |
|
3
Apple
AAPL
$4.45T
| $60.9M | 3.51% |
261,400
| – | – |
|
|
4
AbbVie
ABBV
$442B
| $51.1M | 2.94% |
258,810
-10,000
| -4% | -$1.87M |
|
5
Abbott
ABT
$190B
| $34M | 1.96% |
298,230
| – | – |
|
6
Microsoft
MSFT
$3.74T
| $31M | 1.78% |
72,050
| – | – |
|
7
Zoetis
ZTS
$31.1B
| $28.6M | 1.65% |
146,499
| – | – |
|
8
Merck
MRK
$322B
| $23.7M | 1.36% |
208,500
| – | – |
|
9
Caterpillar
CAT
$388B
| $23.5M | 1.35% |
60,000
| – | – |
|
|
10
Johnson & Johnson
JNJ
$626B
| $23.3M | 1.34% |
143,500
-13,738
| -9% | -$2.19M |
|
11
NVIDIA
NVDA
$5.27T
| $16.8M | 0.97% |
138,500
| – | – |
|
12
Bristol-Myers Squibb
BMY
$130B
| $11.1M | 0.64% |
214,464
| – | – |
|
13
Mastercard
MA
$492B
| $9.88M | 0.57% |
20,000
| – | – |
|
14
Berkshire Hathaway Class B
BRK.B
$1.11T
| $9.78M | 0.56% |
21,241
-3
| -0% | -$1.33K |
|
15
Walt Disney
DIS
$179B
| $9.76M | 0.56% |
101,500
| – | – |
|
16
Procter & Gamble
PG
$338B
| $7.77M | 0.45% |
44,871
| – | – |
|
17
Kimberly-Clark
KMB
$36.1B
| $7.68M | 0.44% |
54,000
| – | – |
|
18
Cigna
CI
$72.4B
| $7.55M | 0.43% |
21,779
| – | – |
|
|
19
Zimmer Biomet
ZBH
$18.5B
| $5.82M | 0.33% |
53,900
-28,800
| -35% | -$3.14M |
|
|
20
Berkshire Hathaway Class A
BRK.A
$1.11T
| $4.15M | 0.24% |
6
| – | – |
|
21
Amazon
AMZN
$2.94T
| $3.75M | 0.22% |
20,100
| – | – |
|
|
22
Kenvue
KVUE
$36.6B
| $3.71M | 0.21% |
160,396
-21,120
| -12% | -$438K |
|
23
Enterprise Products Partners
EPD
$81.8B
| $3.16M | 0.18% |
108,704
| – | – |
|
24
Alphabet (Google) Class C
GOOG
$4.19T
| $2.95M | 0.17% |
17,660
| – | – |
|
|
25
Alphabet (Google) Class A
GOOGL
$4.2T
| $2.65M | 0.15% |
15,980
| – | – |
|
Similar funds
FFH
OCM
AAA
FC
HC
NIM
CC
DCM
Blackhill Capital's Q3 2024 Portfolio in Review
As of Q3 2024, Blackhill Capital held 53 positions worth $1.74B, up 7.7% from $1.61B the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 1.9%. Blackhill Capital opened no new positions and exited 1, leaving the 53-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 70% of assets, up from 69% a quarter earlier, followed by Healthcare and Technology.
- Blackhill Capital's biggest Q3 2024 reduction was Zimmer Biomet, cutting an estimated $3.14M.
- Blackhill Capital fully exited Baxter International in Q3 2024, selling an estimated $167K.
- Blackhill Capital's ten largest holdings make up 93% of its $1.74B portfolio in Q3 2024.
- Blackhill Capital opened 0 new positions and closed 1 in Q3 2024.
- Blackhill Capital's portfolio value rose 7.7% quarter-over-quarter to $1.74B.
Based on Blackhill Capital's 13F filing for Q3 2024, filed 12 Nov 2024.